Rebecca K. Wood

Practice Areas

REBECCA WOOD is Global Co-Lead of the firm’s Food, Drug and Medical Device practice, serves on Sidley’s Global Life Sciences Leadership Council, and leads Sidley’s Washington, D.C. Healthcare and Food, Drug and Medical Device group.

Becky previously served as Chief Counsel (general counsel role) to the Food and Drug Administration (FDA) under former Commissioner Scott Gottlieb, M.D., where she led the Office of Chief Counsel and worked with the Commissioner and Center leadership on a wide range of matters including streamlining the drug and device approval process and modernizing the agency’s regulatory framework.

Becky is recognized for handling the most challenging legal and regulatory issues arising out of FDA regulation, including regenerative medicine (gene and cell therapy), digital health and AI, real-world evidence, combination products, and accelerated approval. Becky has extensive experience representing clients in a wide range of contentious and non-contentious proceedings and engagements at FDA arising throughout the product lifecycle.